Dendritic cells in tissues: In situ stimulation of immunity and immunopathology

Trends in Immunology

Volumn 33, Issue 1, 2012, Pages 8-13

  Bennett, Clare L ^a   Chakraverty, Ronjon ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE ANTIGEN;

CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; DENDRITIC CELL; EFFECTOR CELL; HUMAN; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; INFECTION; INFLAMMATION; MEMORY T LYMPHOCYTE; NONHUMAN; REVIEW; T LYMPHOCYTE;

ANIMALS; DENDRITIC CELLS; HUMANS; IMMUNOLOGIC MEMORY; INFLAMMATION; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 84855322589     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2011.09.008     Document Type: Review

References (54)

1. Maldonado R.A., von Andrian U.H. How tolerogenic dendritic cells induce regulatory T cells. Adv. Immunol. 2010, 108:111-165.
2. Villadangos J.A., Heath W.R. Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells: limitations of the Langerhans cells paradigm. Semin. Immunol. 2005, 17:262-272.
3. Wong P., Pamer E.G. Feedback regulation of pathogen-specific T cell priming. Immunity 2003, 18:499-511.
4. Guarda G., et al. L-selectin-negative CCR7(-) effector and memory CD8(+) T cells enter reactive lymph nodes and kill dendritic cells. Nat. Immunol. 2007, 8:743-752.
5. Boissonnas A., et al. Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes. Immunity 2010, 32:266-278.
6. Belkaid Y., Tarbell K. Regulatory T cells in the control of host-microorganism interactions. Ann. Rev. Immunol. 2009, 27:551-589.
7. Bennett C.L., Clausen B.E. DC ablation in mice: promises, pitfalls, and challenges. Trends Immunol. 2007, 28:525-531.
8. Van Rooijen N., Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 1994, 174:83-93.
9. Heath W.R., Carbone F.R. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 2009, 10:1237-1244.
10. Helft J., et al. Origin and functional heterogeneity of non-lymphoid tissue dendritic cells in mice. Immunol. Rev. 2010, 234:55-75.
11. Legge K.L., Braciale T.J. Accelerated migration of respiratory dendriic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity 2003, 18:265-277.
12. Leon B., et al. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 2007, 26:519-531.
13. Eidsmo L., et al. Differential migration of epidermal and dermal dendritic cells during skin infection. J. Immunol. 2009, 182:3165-3172.
14. GeurtsvanKessel C.H., et al. Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells. J. Exp. Med. 2008, 205:1621-1634.
15. Dominguez P.M., Ardavin C. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol. Rev. 2010, 234:90-104.
16. Geissmann F., et al. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
17. Shi C., et al. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity 2011, 34:590-601.
18. Iijima N., et al. Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:284-289.
19. De Trez C., et al. iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice. PLoS Pathog. 2009, 5:e1000494.
20. Rescigno M., Di Sabatino A. Dendritic cells in intestinal homeostasis and disease. J. Clin. Invest. 2009, 119:2441-2450.
21. Zaba L.C., et al. Resident and " inflammatory" dendritic cells in human skin. J. Invest. Dermatol. 2008, 29:302-308.
22. Connolly M.K., et al. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J. Clin. Invest. 2009, 119:3213-3225.
23. Weber C., et al. CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J. Clin. Invest. 2011, 121:2898-2910.
24. Pamer E.G. Tipping the balance in favor of protective immunity during influenza virus infection. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4961-4962.
25. Bennett C.L., et al. Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin. Blood 2011, 117:7063-7069.
26. Chorro L., et al. Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J. Exp. Med. 2009, 206:3089-3100.
27. McGill J., Legge K.L. Cutting edge: contribution of lung-resident T cell proliferation to the overall magnitude of the antigen-specific CD8 T cell response in the lungs following murine influenza virus infection. J. Immunol. 2009, 183:4177-4181.
28. Reinhardt R.L., et al. Visualizing the generation of memory CD4 T cells in the whole body. Nature 2001, 410:101-105.
29. Harris N.L., et al. Differential T cell function and fate in lymph node and nonlymphoid tissues. J. Exp. Med. 2002, 195:317-326.
30. Lindell D.M., et al. Distinct compartmentalization of CD4+ T-cell effector function versus proliferative capacity during pulmonary cryptococcosis. Am. J. Pathol. 2006, 168:847-855.
31. McGill J., et al. Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs. J. Exp. Med. 2008, 205:1635-1646.
32. McGill J., et al. IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection. J. Exp. Med. 2010, 207:521-534.
33. Dolfi D.V., et al. Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo. J. Immunol. 2011, 186:4599-4608.
34. Hufford M.M., et al. Antiviral CD8+ T cell effector activities in situ are regulated by target cell type. J. Exp. Med. 2011, 208:167-180.
35. Aldridge J.R., et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:5306-5311.
36. McLachlan J.B., et al. Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin. Immunity 2009, 30:277-288.
37. Kang S.S., et al. Migration of cytotoxic lymphocytes in cell cycle permits local MHC I-dependent control of division at sites of viral infection. J. Exp. Med. 2011, 208:747-759.
38. van Panhuys N., et al. Effector lymphoid tissue and its crucial role in protective immunity. Trends Immunol. 2005, 26:242-247.
39. Egawa G., Kabashima K. Skin as a pripheral lymphoid organ: revisiting the concept of skin-associated lymphoid tissues. J. Invest. Dermatol. 2011, 10.1038/jid.2011.198.
40. GeurtsvanKessel C.H., et al. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J. Exp. Med. 2009, 206:2339-2349.
41. Kurts C., et al. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J. Exp. Med. 1998, 188:409-414.
42. Melli K., et al. Amplification of autoimmune response through induction of dendritic cell maturation in inflamed tissues. J. Immunol. 2009, 182:2590-2600.
43. Heymann F., et al. Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J. Clin. Invest. 2009, 119:1286-1297.
44. Teichmann L.L., et al. Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage. Immunity 2010, 33:967-978.
45. Bartholomaüs I., et al. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 2009, 462:94-98.
46. Heath W.R., Villadangos J.A. No driving without a license. Nat. Immunol. 2005, 6:125-126.
47. Behrens G., et al. Helper T cells, dendritic cells and CTL Immunity. Immunol. Cell Biol. 2004, 82:84-90.
48. Zanin-Zhorov A., et al. Protein kinase C-theta mediates negative feedback on regulatory T cell function. Science 2010, 328:372-376.
49. Sporri R., Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat. Immunol. 2005, 6:163-170.
50. Zammit D.J., et al. Dendritic cells maximize the memory CD8 T cell response to infection. Immunity 2005, 22:561-570.
51. Belz G.T., et al. Minimal activation of memory CD8+ T cell by tissue-derived dendritic cells favors the stimulation of naive CD8+ T cells. Nat. Immunol. 2007, 8:1060-1066.
52. Wakim L.M., et al. Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science 2008, 319:198-202.
53. Iijima N., et al. Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus. J. Exp. Med. 2008, 205:3041-3052.
54. Engel D.R., et al. T helper type 1 memory cells disseminate postoperative ileus over the entire intestinal tract. Nat. Med. 2010, 16:1407-1413.